Pharmaceutical Products: Kinshasa, DRC

Location:	District of Columbia
Posted:	May 7, 2026
Due:	May 14, 2026
Agency:	FHI 360
Type of Government:	State & Local
Category:	65 - Medical, Dental, and Veterinary Equipment and Supplies
Solicitation No:	RFQ FY26-EpiC-840-05042026-006_RFQ_02
Publication URL:	To access bid details, please log in.

Attachment Preview

Request for Quote (RFQ)

FY26-EpiC-840-05042026-006

RFQ Number

RFQ Issue Date

Commodity/Service Required:

This Procurement supports:

Submission Instructions:

FY26-EpiC-840-05042026-006

May 7, 2026

Pharmaceutical Products

Meeting Targets and Maintaining Epidemic Control (EpiC) – EpiC DRC

Offers should be submitted electronically in the MS Word/PDF format to the following email

address:

tbachman@@fhi360.org

Attn: Todd Bachman

Title: Senior Director – Administration + Global Procurement Services

With copy to:

Emmanuel Bashaga Kasigwa – Senior Supply Chain Advisor

ebashaga@fhi360.org

And

Offer Due Date:

Expected Award Date:

Offer Validity Period

Jennifer Roggio – Project Manager

jmagalong@fhi360.org

Thursday, May 14, 2026; 1400 Hours ET (Washington DC)

May 31, 2026

90 days from the date specified for the receipt of offers

CIF: Cost, Insurance, Freight

Address: 4630, Avenue de la Science 365 offices building, Kinshasa, Democratic Republic

of Congo

Disclaimer

See page 6 – TABLE 2 FOR ADDITIONAL PRICING REQUIREMENTS

• Reserves the right to cancel this solicitation and not make any award.

• May reject any or all responses received.

• Reserves the right to disqualify any offer based on Offeror failure to follow solicitation

instructions.

• Reserves the right to issue award based on initial evaluation of offers without further

discussion.

• Reserves the right to award only part of the activities in the solicitation.

• Reserves the right to waive minor proposal deficiencies that can be corrected prior to

award determination to promote competition

Attachments to RFQ:

1. Attachment “A” – Commodity Specifications or Statement of Work Requirements

2. Attachment “B” – Instructions to Bidders/Sellers

3. Attachment “C” – Supplemental Terms & Conditions

All bidders/sellers are responsible to carefully review each attachment and follow any instructions that may be

relevant to this procurement.

Attachment A

Commodity Specifications or Statement of Work

Purpose

This RFQ invites qualified suppliers to submit quotes to supply pharmaceutical products listed in Table 1 below to the

Democratic Republic of the Congo (DRC). FHI 360 needs to acquire these commodities to improve maternal, newborn and

child health (MNCH), nutrition, and malaria outcomes in DRC. These commodities are to be acquired by FHI 360 under a

United States Government-funded cooperative agreement or other donor-funded agreement should the need arise.

Therefore, Offerors are required to comply with all applicable federal assistance requirements, including specific Federal

Acquisition Regulation (FAR) clauses and other terms that are incorporated by reference as required by the applicable

award and as specified within this RFQ.

FHI 360 may elect to award a single Fixed Price Contract (FPC) or to award multiple Fixed Price Contracts for the same or

similar supplies or services, if any, to two or more sources under this solicitation as determined to be in the best interest of

the company.

Offerors intending to submit quotes are required to promptly acknowledge receipt of this original

solicitation to the FHI 360 contacts listed on the cover page.

Deliverables, Timelines, Special Terms and Conditions:

Deliverable

List of commodities

below

Timeline

Estimated Award

Date is May 31,

2026

Special Terms & Conditions

• Bidder shall adhere to the quality, packaging, and

labelling guidance provided in Attachment C.

• Bidder shall provide all required product and shipping

paperwork to facilitate in-country delivery and clearance of

procured products.

• Bidder shall provide temperature data logging upon

shipping cargo.

• Upon completion of packaging, Supplier sends complete

shipping documents to the Client and waits for Green

Light to ship allowing preclearance.

• Supplier must submit commodities in stock and shortest

lead time.

• Supplier must ensure container descriptions and units per

container matches requested quantities / container

description or specify the container description offered.

• The Pharmaceuticals provided under this Contract

should have at least 75% shelf life from the date of

Delivery.

• Certificates of Analysis (CoA), Certificate of Origin

(CoO), GMP certificates of the medicines should be

provided prior to shipping the medicines.

• Bidder shall provide estimated Air freight fees to

Kinshasa, DRC at the time of submitting quote (freight

quote must include estimated insurance and cost of

temperature-controlled reefer container for items

quoted).

Table 1: List of Pharmaceutical Products

Name of

Pharmaceutical

Strength / Quantity of

Dosage Form Containers

(number of

bottles, vials)

Size of container

(Unit of

Issue (U/I)

Oxytocin

10 IU/mL (1

mL) ampoule

Tranexamic Acid

Amoxicillin

100 mg/mL (5

mL) IV

Ampoule

500 mg

capsule

Metronidazole

Magnesium

Sulfate

Calcium Gluconate

5 mg/mL (100

mL) infusion

bottle

500 mg/mL

(10 mL)

ampoule

10% (10 mL)

vial

Methyldopa

250 mg tablet

4,230

2,470

9,280

490

3,900

970

2,460

100 ampoules

10 ampoules

500 capsules

96 bottles

10 ampoules

1 vial

100 tablets

Ampicillin

1 g injectable

powder/vial

Ceftriaxone +

Water for Injection

1g injectable

powder/vial

Gentamicin

20 mg/mL (2

mL) ampoule

Dexamethasone

4 mg/mL (2

mL) ampoule

1,005,000

12,200

456

1,900

1 vial

10 vials

50 ampoules

10 ampoules

Cost

per

Contain

er or U/I

(USD)

Extended

Cost

(USD)

(quantity

x cost)

Amoxicillin

Oral Rehydration

Salts + Zinc

Sulfate

Micronutrient

preparation

(UNIMMAP)

Vitamin A 100 000

250 mg

dispersible

tablet

Kit (20.5 gm/L

+ 20 mg

tablet)

N/A

100 000 UI

capsule

Vitamin A 200 000

200 000 UI

capsule

Carbetocin

Total Cost of

Pharmaceuticals:

100 mcg/mL,

solution for

injection, 1

mL ampoule

63,170

30,700

84,220

4,748

35,374

33,605

100 tablets (blister)

Kit (2 sachets + 10 tablets)

100 tablets

100 capsules

10 ampoules

$0.00

By signing this attachment, the bidder confirms he has a complete understanding of the specifications and fully intends to

deliver items that comply with the above listed specifications.

Signature:

Title:

Date:

Attachment “B”

Instructions to Bidders/Sellers

1. Procurement Narrative Description: FHI 360 intends to purchase commodities identified in

Attachment A. The term of the Ordering Agreement shall be from Award Date to the Delivery date of

the Offeror unless extended by mutual agreement of the parties. The Buyer intends to award to a

single approved supplier based on conformance to the listed specifications, the ability to service this

contract, and selling price. We reserve the right to award to more than one bidder. If an Ordering

Agreement is established as a result of this RFQ, supplier understands that quantities indicated in the

specifications (Attachment A) are an estimate only and FHI 360 does not guarantee the purchase

quantity of any item listed.

2. Procuring Activity: This procurement will be made by Family Health International (FHI 360),

located at 359 Blackwell Street, Suite 200, Durham, NC 27701, USA.

3. Proposal Requirements. All Sellers will submit a quote/proposal which contains offers for all items

and options included in this RFQ. All information presented in the Sellers quote/proposal will be

considered during FHI 360’s evaluation. Failure to submit the information required in this RFQ may

result in Seller’s offer being deemed non-responsive.

Sellers are responsible for submitting offers, and any modifications, revisions, or withdrawals, so as to

reach FHI 360’s office designated in the RFQ by the time and date specified in the RFQ. Any offer,

modification, revision, or withdrawal of an offer received at the FHI 360 office designated in the RFQ

after the exact time specified for receipt of offers is “late” and may not be considered at the discretion

of FHI 360 Procurement office. The Seller’s proposal shall include the following:

(a) The solicitation number:

(b) The date and time submitted:

same:

(d) Validity period of Quote:

(e) A technical description of the items being offered in sufficient detail to evaluate compliance with

the requirements in the solicitation. This may include product literature, or other documents, if

necessary.

(f) Lead Time Availability of the Commodity/Service. If suppliers offering any alternative it must be

communicated and confirmed before the bid closure.

(g) Supplier must specify the expiry date of the product.

(h) Special pricing instructions: Price and any discount terms or special requirements or terms

(special note: pricing must include guaranteed firm fixed prices for items requested.

(i) Payment address or instructions (if different from mailing address)

(j) Acknowledgment of solicitation amendments (if any)

4. Forms: Sellers (potential bidders or suppliers) must record their pricing using the format found on

Attachment “A”. Sellers must sign the single hard copy submitted and send to address listed on the

cover page of this RFQ.

5. Questions Concerning the Procurement: All questions regarding this RFQ to be directed to Todd

Bachman, Senior Director – Global Procurement Services (tbachman@fhi360.org), with

Emmanuel Bashaga Kasigwa (ebashaga@fhi360.org) and Jennifer Roggio (jmagalong@fhi360.org)

in copy . The due date and time for questions is Monday, May 11, 2026 no later than 1400 Hours ET

(Washington, DC)

This is the opportunity summary page. It provides an overview of this opportunity and a preview of the attached documentation.

Pharmaceutical Products: Kinshasa, DRC

Attachment Preview

See also